44 related articles for article (PubMed ID: 21398385)
1. Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer.
Bossi P; Orlandi E; Bergamini C; Locati LD; Granata R; Mirabile A; Parolini D; Franceschini M; Fallai C; Olmi P; Quattrone P; Potepan P; Gloghini A; Miceli R; Mattana F; Scaramellini G; Licitra L
Ann Oncol; 2011 Nov; 22(11):2495-2500. PubMed ID: 21398385
[TBL] [Abstract][Full Text] [Related]
2. Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma.
Zhong LP; Zhang CP; Ren GX; Guo W; William WN; Sun J; Zhu HG; Tu WY; Li J; Cai YL; Wang LZ; Fan XD; Wang ZH; Hu YJ; Ji T; Yang WJ; Ye WM; Li J; He Y; Wang YA; Xu LQ; Wang BS; Kies MS; Lee JJ; Myers JN; Zhang ZY
J Clin Oncol; 2013 Feb; 31(6):744-51. PubMed ID: 23129742
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001).
Nicholson S; Hall E; Harland SJ; Chester JD; Pickering L; Barber J; Elliott T; Thomson A; Burnett S; Cruickshank C; Carrington B; Waters R; Bahl A
Br J Cancer; 2013 Nov; 109(10):2554-9. PubMed ID: 24169355
[TBL] [Abstract][Full Text] [Related]
4. Phase II Study of Adjuvant Chemoradiotherapy Using Docetaxel/Cisplatin/5-Fluorouracil Before and After Intensity-modulated Radiotherapy With Concurrent Docetaxel in Patients With Completely (R0) Resected Gastric Carcinoma.
Liu Y; Zhao G; Xu Y; Zhang T; Chen Z; Yan G; Tu W; Hu Y; Chen Y; He X; Li X; Chen H; Yao S; Hu Z; Chen X; Chen T
Am J Clin Oncol; 2018 Jul; 41(7):619-625. PubMed ID: 28263232
[TBL] [Abstract][Full Text] [Related]
5. Combination of nivolumab with standard induction chemotherapy in children and adults with EBV-positive nasopharyngeal carcinoma : Protocol of a prospective multicenter phase 2 trial.
Römer T; Vokuhl C; Staatz G; Mottaghy FM; Christiansen H; Eble MJ; Timmermann B; Klussmann JP; Elbracht M; Calaminus G; Zimmermann M; Brümmendorf TH; Feuchtinger T; Kerp H; Kontny U
HNO; 2024 Jun; 72(6):423-439. PubMed ID: 38214716
[TBL] [Abstract][Full Text] [Related]
6. Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial.
Guo SS; Yang JH; Sun XS; Liu LZ; Yang ZC; Liu LT; Liu SL; Li XY; Lv XF; Luo DH; Li JB; Liu Q; Wang P; Guo L; Mo HY; Sun R; Yang Q; Liang YJ; Jia GD; Zhao C; Chen QY; Tang LQ; Mai HQ
Eur J Cancer; 2023 Nov; 194():113336. PubMed ID: 37801967
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA-IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trial.
Luo DH; Li XY; Guo SS; Guo WP; Liu LT; Mo HY; Guo L; Lv XF; Liu LZ; Li JB; Liu Q; Wang P; Sun XS; Liu SL; Chen QY; Tang LQ; Mai HQ
Lancet Reg Health West Pac; 2023 Nov; 40():100895. PubMed ID: 37691885
[TBL] [Abstract][Full Text] [Related]
8. Phase I Study to Determine MTD of Docetaxel and Cisplatin with Concurrent Radiation Therapy for Stage III Non-Small Cell Lung Cancer.
Li YQ; Shi AH; Li FH; Yu R; Zhu GY
Chin J Cancer Res; 2011 Jun; 23(2):129-33. PubMed ID: 23482452
[TBL] [Abstract][Full Text] [Related]
9. An Evaluation of Treatment Outcomes and Associated Factors in Nasopharyngeal Cancer Patients at a Tertiary Cancer Center in the United Arab Emirates.
Bin Sumaida A; Shanbhag NM; Aby Ali HA; Jaafar N; AlKaabi K; Balaraj K
Cureus; 2024 Feb; 16(2):e54344. PubMed ID: 38371438
[TBL] [Abstract][Full Text] [Related]
10. Elevated growth differentiating factor 15 expression predicts long-term benefit of docetaxel, cisplatin and 5-fluorouracil induction chemotherapy in patients with oral cancer.
Tang X; Hu YJ; Ju WT; Fu Y; Sun WW; Liu Y; Tan YR; Wang LZ; Li J; Tu YY; Zhang CP; Zhang ZY; Zhong LP
Oncol Lett; 2018 May; 15(5):8118-8124. PubMed ID: 29731919
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight cases.
Seto A; Sugitani I; Toda K; Kawabata K; Takahashi S; Saotome T
Surg Today; 2013 Oct; ():. PubMed ID: 24122002
[TBL] [Abstract][Full Text] [Related]
12. Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma.
Lee AW; Ngan RK; Tung SY; Cheng A; Kwong DL; Lu TX; Chan AT; Chan LL; Yiu H; Ng WT; Wong F; Yuen KT; Yau S; Cheung FY; Chan OS; Choi H; Chappell R
Cancer; 2015 Apr; 121(8):1328-38. PubMed ID: 25529384
[TBL] [Abstract][Full Text] [Related]
13. Induction Chemotherapy Followed by Radiotherapy vs Chemoradiotherapy in Nasopharyngeal Carcinoma: A Randomized Clinical Trial.
Dai J; Zhang B; Su Y; Pan Y; Ye Z; Cai R; Qin G; Kong X; Mo Y; Zhang R; Liu Z; Xie Y; Ruan X; Jiang W
JAMA Oncol; 2024 Apr; 10(4):456-463. PubMed ID: 38329737
[TBL] [Abstract][Full Text] [Related]
14. Induction chemotherapy followed by radiotherapy
Liu LT; Liang YJ; Guo SS; Mo HY; Guo L; Wen YF; Xie HJ; Tang QN; Sun XS; Liu SL; Li XY; Yang JH; Yang ZC; Tang LQ; Chen QY; Mai HQ
Ther Adv Med Oncol; 2020; 12():1758835920928214. PubMed ID: 32536983
[TBL] [Abstract][Full Text] [Related]
15. Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA level.
Liu SL; Sun XS; Xie HJ; Chen QY; Lin HX; Liang H; Liang YJ; Li XY; Yan JJ; Lin C; Yang ZC; Guo SS; Liu LT; Tang QN; Du YY; Tang LQ; Guo L; Mai HQ
BMC Cancer; 2020 Feb; 20(1):89. PubMed ID: 32013967
[TBL] [Abstract][Full Text] [Related]
16. Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma.
Liu SL; Sun XS; Li XY; Chen QY; Lin HX; Wen YF; Guo SS; Liu LT; Xie HJ; Tang QN; Liang YJ; Yan JJ; Lin C; Yang ZC; Tang LQ; Guo L; Mai HQ
BMC Cancer; 2018 Dec; 18(1):1279. PubMed ID: 30572856
[TBL] [Abstract][Full Text] [Related]
17. Induction chemotherapy followed by intensity-modulated radiotherapy with reduced gross tumor volume delineation for stage T3-4 nasopharyngeal carcinoma.
Xue F; Hu C; He X
Onco Targets Ther; 2017; 10():3329-3336. PubMed ID: 28740408
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of concurrent chemoradiotherapy with high-dose cisplatin after induction TPF chemotherapy in head and neck cancer: a critical review of the literature and the experience of the European Institute of Oncology.
Alterio D; Cossu Rocca M; Russell-Edu W; Dicuonzo S; Fanetti G; Marvaso G; Preda L; Zorzi S; Verri E; Nole' F; Jereczek-Fossa BA
Med Oncol; 2017 May; 34(5):86. PubMed ID: 28391578
[TBL] [Abstract][Full Text] [Related]
19. Use of taxane-containing induction chemotherapy in combination with concurrent chemoradiotherapy in Chinese patients with locally advanced nasopharyngeal carcinoma: a meta-analysis.
Tian R; Ye HX; Zhang BG; Gu DY; Zhang BW; Teng ZP; Jin MY; Chen JF; Qi JW
Onco Targets Ther; 2015; 8():3255-63. PubMed ID: 26604792
[TBL] [Abstract][Full Text] [Related]
20. Role of chemotherapy in nasopharyngeal carcinoma.
Paiar F; Di Cataldo V; Zei G; Pasquetti EM; Cecchini S; Meattini I; Mangoni M; Agresti B; Iermano C; Bonomo P; Biti G
Oncol Rev; 2012 Mar; 6(1):e1. PubMed ID: 25992199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
